Merck, Eisai to shut down late stage study for combo cancer therapy Ruchika Sharma28 Aug 2023 12:31 PM ISTThe companies are testing the combination to treat a range of cancers, including those affecting the lungs and stomach.
CHMP recommends nod of Merck Keytruda in combo with trastuzumab, chemotherapy to treat HER2-positive advanced GEJ adenocarcinoma expressing PD-L1 Ruchika Sharma24 July 2023 2:30 PM ISTRahway:Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
USFDA accepts application for Merck KEYTRUDA plus chemotherapy as treatment for Biliary Tract Cancer Ruchika Sharma9 Jun 2023 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for review...
MSD Pharma Gets CDSCO Panel Nod for additional indication of anticancer drug Pembrolizumab Dr. Divya Colin23 May 2023 6:00 PM ISTNew Delhi: Based on the global clinical trial data presented by drug major, MSD Pharmaceuticals, the Subject Expert Committee (SEC) functional under...
Merck beats first-quarter expectations on Keytruda, Gardasil strength Ruchika Sharma30 April 2023 4:00 PM ISTBengaluru: Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster...
Merck-Moderna vaccine helps keep patients free from skin cancer Roshni Dhar17 April 2023 6:00 PM ISTAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by...
Health Bulletin 17/April/2023 Roshni Dhar17 April 2023 4:29 PM ISTHere are the top health stories for the day:NEET UG 2023: NTA revises eligibility criteria for Indian candidates abroadThe NEET exam conducting body...
Moderna, Merck cancer vaccine plus Keytruda delays skin cancer return Ruchika Sharma17 April 2023 3:59 PM ISTThe vaccine is custom-built based on an analysis of a patient's tumors after surgical removal.
USFDA accepts application for Merck KEYTRUDA plus Chemotherapy as first line treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Ruchika Sharma14 April 2023 11:00 AM ISTKEYTRUDA is an anti-programmed death receptor-1 therapy that works by increasing the ability of the body's immune system to help detect and fight...
Merck, Moderna get PRIME scheme designation from EMA for personalized mRNA cancer vaccine, KEYTRUDA combo for adjuvant treatment of High-risk Melanoma Ruchika Sharma9 April 2023 2:30 PM ISTMelanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells.
Setback: Merck, Eisai to stop late-stage study of Keytruda plus Lenvima for metastatic melanoma Ruchika Sharma8 April 2023 2:01 PM ISTThey also said another late-stage trial for Keytruda and Lenvima did not meet its main goal of overall survival for treating a type of colorectal or...
Merck gets USFDA nod for Keytruda in combination with Padcev to treat Advanced or Metastatic Urothelial Cancer Ruchika Sharma5 April 2023 1:16 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
